An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally advanced (LA) nasopharyngeal carcinoma (NPC): A 2-year follow-up report.
Chun-yan Chen
No relevant relationships to disclose
Chong Zhao
No relevant relationships to disclose
Li Gao
No relevant relationships to disclose
Jin-yi Lang
No relevant relationships to disclose
Jian-ji Pan
No relevant relationships to disclose
Chao-su Hu
No relevant relationships to disclose
Feng Jin
No relevant relationships to disclose
Ren-sheng Wang
No relevant relationships to disclose
Conghua Xie
No relevant relationships to disclose
Tongyu Lin
No relevant relationships to disclose
Tai-xiang Lu
No relevant relationships to disclose